← Eichor
Study identifier: NCT06565416 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial

Condition: Opioid Use Disorder · Opioid Misuse · Chronic Pain  ·  Sponsor: University of New Mexico

PhaseNA
Planned participants225
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The present study seeks to examine the implementation process of culturally tailoring screening and brief intervention for both chronic pain and opioid misuse/opioid use disorder in three American Indian and Alaska Native (AI/AN) serving clinics. The investigators also will assess staff perspectives on this implementation as well as a survey to understand clients at these sites who have chronic pain and opioid misuse/opioid use disorder.

This description comes directly from the study's public registry record.

Talk to the study team

Kamilla L Venner, PhD  ·  5059252300  ·  kamilla@unm.edu

Angel R Vasquez, PhD  ·  vasquez@unm.edu

Always discuss trial participation with your own doctor first.

Locations (3)

Clinic Site A (blinded pending tribal approval)Arcata, California, United StatesRecruiting
Clinic Site C (blinded pending tribal approval)Minneapolis, Minnesota, United StatesNot Yet Recruiting
Clinic Site B (blinded pending tribal approval)Toppenish, Washington, United StatesNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06565416